Viva in Vitro Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.58M
- Investors
-
7
Viva in Vitro General Information
Description
Developer of a patient assessment technique designed to detect NLRP3 immunoparalysis in patients. The company develops advanced and easy-to-use devices to solve the current problem of stratification of patients in sepsis, and in other inflammatory processes and specializes in inflammasome research and development, enabling healthcare firms to improve the stratification and treatment of patients with sepsis and other inflammatory conditions.
Contact Information
Website
www.vivaivd.comCorporate Office
- Murcia Science Park, Building T
- 1st floor, module T1/3. Ctra. Madrid km. 388
- 30100 Murcia
- Spain
Corporate Office
- Murcia Science Park, Building T
- 1st floor, module T1/3. Ctra. Madrid km. 388
- 30100 Murcia
- Spain
Viva in Vitro Timeline
Viva in Vitro Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Grant | 24-Jan-2025 | $2.58M | Completed | Pre-Clinical Trials | ||
| 7. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
| 6. Early Stage VC | 10-Jul-2024 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 4. Grant | Completed | Pre-Clinical Trials | ||||
| 3. Early Stage VC | 24-Feb-2023 | Completed | Pre-Clinical Trials | |||
| 2. Angel (individual) | 01-Jan-2022 | $311K | $311K | Completed | Pre-Clinical Trials | |
| 1. Grant | 01-Jan-2022 | $220K | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Viva in Vitro Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Viva in Vitro Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Viva in Vitro Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| NEOTEC | Venture Capital | Minority |
Viva in Vitro FAQs
-
When was Viva in Vitro founded?
Viva in Vitro was founded in 2021.
-
Where is Viva in Vitro headquartered?
Viva in Vitro is headquartered in Murcia, Spain.
-
What is the size of Viva in Vitro?
Viva in Vitro has 8 total employees.
-
What industry is Viva in Vitro in?
Viva in Vitro’s primary industry is Diagnostic Equipment.
-
Is Viva in Vitro a private or public company?
Viva in Vitro is a Private company.
-
What is Viva in Vitro’s current revenue?
The current revenue for Viva in Vitro is .
-
How much funding has Viva in Vitro raised over time?
Viva in Vitro has raised $3M.
-
Who are Viva in Vitro’s investors?
European Innovation Council, , , , and NEOTEC are 5 of 7 investors who have invested in Viva in Vitro.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
